|
YY1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.878790E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.009000E-01 |
| Normal-vs-Stage2 |
7.096400E-01 |
| Normal-vs-Stage3 |
6.568400E-02 |
| Normal-vs-Stage4 |
3.993700E-02 |
| Stage1-vs-Stage2 |
6.276200E-01 |
| Stage1-vs-Stage3 |
2.030800E-01 |
| Stage1-vs-Stage4 |
1.959640E-01 |
| Stage2-vs-Stage3 |
2.197800E-01 |
| Stage2-vs-Stage4 |
1.773600E-01 |
| Stage3-vs-Stage4 |
7.850600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.700200E-01 |
| Normal-vs-AfricanAmerican |
9.200800E-01 |
| Normal-vs-Asian |
1.021960E-01 |
| Caucasian-vs-AfricanAmerican |
4.138200E-01 |
| Caucasian-vs-Asian |
5.789000E-01 |
| AfricanAmerican-vs-Asian |
2.981600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.633770E-01 |
| Normal-vs-Female |
2.218200E-01 |
| Male-vs-Female |
7.277400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.795000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.260770E-01 |
| Normal-vs-Age(61-80Yrs) |
1.977350E-01 |
| Normal-vs-Age(81-100Yrs) |
3.132800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.638200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.875000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.182000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.164600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.376800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.664600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.773800E-01 |
| Classical-VS-Follicular |
6.425400E-01 |
| Classical-VS-Other |
8.837800E-01 |
| Classical-VS-Normal |
3.881200E-01 |
| Tall-VS-Follicular |
6.651600E-01 |
| Tall-VS-Other |
5.469400E-01 |
| Tall-VS-Normal |
1.552020E-01 |
| Follicular-VS-Other |
7.876200E-01 |
| Follicular-VS-Normal |
2.802200E-01 |
| Other-VS-Normal |
8.269400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.390000E-01 |
| Normal-vs-N1 |
4.628000E-02 |
| N0-vs-N1 |
3.961600E-01 |
|
|
